This short communication accompanies my presentation at the International
Congress on Sudden Cardiac Death held in Prague, March 30 – April 1,
2017. It summarizes briefly studies of the cardiac electrophysiological
substrate in patients with hereditary arrhythmogenic syndromes – the
Long QT and Brugada syndromes – conducted noninvasively, in
situ, using Electrocardiographic Imaging (ECGI). The same
noninvasive approach was used to map the electrophysiological substrate of a
post-infarction myocardial scar and to relate this substrate to the pattern of
activation during reentrant ventricular tachycardia. My thoughts about a
potential role for ECGI in cardiac research and clinical care are also expressed
briefly, with examples from on-going work in my laboratory.